DGEFX
Price
$14.42
Change
-$0.09 (-0.62%)
Updated
Nov 13 closing price
Net Assets
479.52M
JGECX
Price
$13.25
Change
-$0.15 (-1.12%)
Updated
Nov 13 closing price
Net Assets
723.34M
Interact to see
Advertisement

DGEFX vs JGECX

Header iconDGEFX vs JGECX Comparison
Open Charts DGEFX vs JGECXBanner chart's image
Destinations Equity Income I
Price$14.42
Change-$0.09 (-0.62%)
VolumeN/A
Net Assets479.52M
JHancock Global Equity C
Price$13.25
Change-$0.15 (-1.12%)
VolumeN/A
Net Assets723.34M
DGEFX vs JGECX Comparison Chart in %
View a ticker or compare two or three
VS
DGEFX vs. JGECX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGEFX is a Buy and JGECX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JGECX has more cash in the bank: 723M vs. DGEFX (480M). DGEFX pays higher dividends than JGECX: DGEFX (2.20) vs JGECX (0.20). DGEFX was incepted earlier than JGECX: DGEFX (9 years) vs JGECX (11 years). JGECX (2.01) is less costly to investors than DGEFX (1.07). DGEFX is a more actively managed with annual turnover of: 45.00 vs. JGECX (36.00). DGEFX has a lower initial minimum investment than JGECX: DGEFX (0) vs JGECX (1000). DGEFX annual gain was more profitable for investors over the last year : 14.08 vs. JGECX (-2.07). DGEFX return over 5 years is better than : 69.53 vs. JGECX (5.92).
DGEFXJGECXDGEFX / JGECX
Total Expense Ratio0.942.0047%
Annual Report Gross Expense Ratio1.072.0153%
Fund Existence9 years11 years-
Gain YTD16.90313.734123%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets480M723M66%
Annual Yield % from dividends2.200.201,103%
Returns for 1 year14.08-2.07-680%
Returns for 3 years37.5920.53183%
Returns for 5 years69.535.921,174%
Returns for 10 yearsN/A32.17-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACBU10.41N/A
N/A
Artius II Acquisition Inc
MSDL16.72-0.04
-0.24%
Morgan Stanley Direct Lending Fund
KOSS4.80-0.12
-2.44%
Koss Corp
CTNM10.90-0.57
-4.97%
Contineum Therapeutics
GTLB43.97-2.48
-5.34%
GitLab